Trial NCT02373865

View at ClinicalTrials.gov 
Org. Study IDs: DIA-2-REDESIGN

Last trial update was posted on 2019-02-27

MeSH Interventions

Glimepiride Sitagliptin Phosphate

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2 Hypoglycemia

Other Conditions

Diabetes Mellitus Type 2

Stopping Reasons

Premature termination due to insufficient patient recruitement..

Limitations And Caveats

Limitations of the study: deceleration of patient recruitment, break up of patient recruitment, descriptive reporting of patient characteristics of 4 enrolled patients (no statistically reliable results are available)

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID